查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576951

癌症放射治疗设备 - 市场考察，竞争情形，市场预测(2030年)

Radiotherapy/Radiation Oncology Devices - Market Insights, Competitive Landscape, and Market Forecast -2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2024年至2030年的预测期内，全球癌症放射治疗设备市场规模预计将以7.78%的复合年增长率成长。由于各类癌症患者数量的增加、市场参与者推出创新产品组合以及人们对早期检测的认识不断增强，该市场正在经历显着增长，预计在 2024-2030 年预测期内将有所增加。将成为加速整体市场成长的因素。

癌症放射治疗设备市场动态

根据世界卫生组织（WHO）2024年提供的数据，国际癌症研究机构（IARC）表示，2022年全球新增癌症病例达2,000万例。根据相同数据，在新登记的癌症患者中，肺癌是最常见的癌症，占全球新患者的250万人。其次是乳癌（230 万）、大肠癌（190 万）和胃癌（97 万）。

全球癌症观察站（2024）估计，到2030年，全球新增癌症患者数将达到2,000万至2,410万。根据统计，亚洲有9,826,539人，欧洲有4,471,422人，拉丁美洲和加勒比海地区有1,551,060人，非洲有1,185,216人。

越来越多的患者被诊断出患有各种癌症，迫使卫生系统实施先进的放射治疗技术，以提供有效的治疗选择。患者数量的增加正在推动对放射肿瘤学基础设施和创新设备的进一步投资，从而提振市场。

市场主要参与者增加的产品开发活动预计将促使癌症放射治疗设备的市场成长。例如，2024年5月，GE HealthCare在2024年欧洲治疗放射学和肿瘤学会（ESTRO）上宣布了其新的Revolution RT放射治疗CT系统。据供应商称，新系统采用大口径 CT 平台设计，还包括与 Spectronic MRI Planner 介接的人工智慧增强版智慧放射治疗 (iRT) 平台。

因此，上述所有因素的交互作用预计将在 2024-2030 年预测期内推动癌症放射治疗设备市场的发展。

然而，与辐射和替代治疗的可用性相关的风险因素可能会限制癌症放射治疗设备市场的成长。

癌症放疗设备市场区隔分析

在癌症放射治疗设备市场类型领域，立体定位高级电子/钴 60 线性加速器的伽玛刀子类别预计将在 2023 年占据重要的收入占有率。这是因为伽玛刀应用广泛，具有多种益处，可以增强对不同类型慢性疾病的管理。

伽玛刀是一种用多束辐射束从不同角度照射大脑特定部位的技术。每束光束都太弱，无法损坏健康组织，因此它会自行通过，造成的伤害很小。伽玛刀还可以提供大剂量的辐射，对周围健康的组织和结构没有或很少造成损害，从而减少出血、感染和脑脊髓液漏等併发症。另一个优点是它不需要全身麻醉，因此没有相关的潜在副作用，只需要一次治疗。

此外，多家市场公司拥有强大的产品组合，领先的公司如Leksell、GammaKnife(R) Icon(TM)、Leksell Gamma Knife(R) Lightning、Leksell Gamma Knife(R) 我们提供广泛的伽玛刀产品，包括 Perfexion(TM)。

因此，伽玛刀的广泛应用和各种优势提高了其性能和易用性，预计这将对2024-2030年预测期内的整体癌症放射治疗设备市场成长产生重大影响。

本报告提供全球癌症放射治疗设备市场相关调查分析，提供各地区市场规模与预测，过去3年的产品/技术开发，市场主要企业，未来的机会等资讯。

目录

第1章 癌症放射治疗设备市场报告的简介

第2章 癌症放射治疗设备市场摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 癌症放射治疗设备市场主要原因的分析

  • 癌症放射治疗设备市场促进因素
  • 癌症放射治疗设备市场阻碍因素与课题
  • 癌症放射治疗设备市场机会

第6章 癌症放射治疗设备市场波特的五力分析

第7章 癌症放射治疗设备市场评估

  • 各类型
    • 外部照射放射治疗
    • 内部照射放射治疗/近距离放射治疗治疗
  • 各技术
  • 各用途
    • 内部照射放射治疗
  • 各终端用户
    • 医院
    • 独立放射治疗中心
    • 其他
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 癌症放射治疗设备市场企业与产品的简介

  • Siemens Healthineers AG
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide
  • BD
  • Isoray Inc.
  • Mevion Medical Systems
  • Viewray Technologies, Inc.
  • Eckert & Ziegler BEBIG
  • ZEISS
  • GT Medical Technologies, Inc.
  • Hitachi, Ltd.
  • iCAD, Inc.
  • IntraOp Medical, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • SIT - S.I.T. Sordina IORT Technologies S.p.A.
  • Sensus Healthcare, Inc.
  • Theragenics
  • Optivus Proton Therapy, Inc.
  • P-cure

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明，咨询方式

Product Code: DIMDCL0513

Radiotherapy/Radiation Oncology Devices Market by Type (External Beam Radiation Therapy [Linear Accelerators (Linac), Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators [Gamma Knife, CyberKnife, and TomoTherapy], Proton Therapy, Cyclotron, Synchrotron, and Others], and Internal Beam Radiotherapy/Brachytherapy), Technology (External Beam Radiation Therapy [Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), and Others] and Internal Beam Radiotherapy/Brachytherapy [Low-Dose Rate Brachytherapy and High-Dose Rate Brachytherapy], Application (External Beam Radiation Therapy [Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, and Others] and Internal Beam Radiation Therapy [Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer, and Others], End-User (Hospitals, Independent Radiotherapy Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of cancer and the rising product developmental activities worldwide

The radiotherapy/radiation oncology devices market is projected to grow at a 7.78% CAGR during the forecast period from 2024 to 2030. The radiotherapy/radiation oncology devices market is growing significantly due to the increasing cases of different types of cancers among the population, the introduction of innovative product portfolios by market players, and the growing awareness for early detection are factors that are expected to escalate the overall growth of the radiotherapy/radiation oncology devices market during the forecast period from 2024 to 2030.

Radiotherapy/Radiation Oncology Devices Market Dynamics:

According to data provided by the World Health Organization in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. As per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. Next in order of incidence was breast cancer with 2.3 million cases, colon cancer with 1.9 million cases, and stomach cancer with 0.97 million cases globally.

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by the year 2030. It stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

As more patients are diagnosed with various cancers, healthcare systems are compelled to adopt advanced radiotherapy technologies to provide effective treatment options. This growing patient population is further driving investments in radiation oncology infrastructure and innovative devices and thereby boosting the market for same.

Increased product developmental activities by market key players is slated to witness market growth for radiotherapy/radiation oncology devices. For example, in May 2024, GE HealthCare unveiled its new Revolution RT radiation therapy CT system at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024. The new system was designed with a wide-bore CT platform and includes an updated AI-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic MRI Planner, according to the vendor.

Hence, the interplay of all the above-mentioned factors are expected to drive the market for radiotherapy/radiation oncology devices market during the given forecast period from 2024 to 2030.

However, risk factors associated with radiation, and the availability of alternative therapies, among others may restrict the market growth of radiotherapy/radiation oncology devices.

Radiotherapy/Radiation Oncology Devices Market Segment Analysis:

Radiotherapy/Radiation Oncology Devices Market by Type (External Beam Radiation Therapy [Linear Accelerators (Linac), Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators [Gamma Knife, CyberKnife, and TomoTherapy], Proton Therapy, Cyclotron, Synchrotron, and Others], and Internal Beam Radiotherapy/Brachytherapy), Technology (External Beam Radiation Therapy [Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), and Others] and Internal Beam Radiotherapy/Brachytherapy [Low-Dose Rate Brachytherapy and High-Dose Rate Brachytherapy], Application (External Beam Radiation Therapy [Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, and Others] and Internal Beam Radiation Therapy [Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer, and Others], End-User (Hospitals, Independent Radiotherapy Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the radiotherapy/radiation oncology devices market, the gamma knife sub- category of stereotactic advanced electron/cobalt-60 linear accelerators is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various advantages of gamma knife that enhance the management of different type of chronic conditions.

Gama knife is a technique that uses numerous beams of radiation from various angles to target a specific area of the brain. Since each beam is too weak to harm the healthy tissue, it passes through on its own and is less harmful. Gamma knife also allows a powerful dose of radiation to be delivered with no or minimal damage to healthy surrounding tissue and structures and results in fewer complications such as bleeding, infection, or cerebrospinal fluid leakage. Another added advantage is that it requires no general anesthesia, eliminating the related potential side effects, and is performed in a single session, often on an outpatient basis and only occasionally requiring an overnight stay.

Moreover, several market players have a strong portfolio and key players like Leksell has a broad range of GammaKnife product offerings, some of them are Gamma Knife(R) Icon(TM), Leksell Gamma Knife(R) Lightning, Leksell Gamma Knife(R) Perfexion(TM), are now actively being involved to develop radiotherapy/radiation oncology devices.

Therefore, the widespread uses and various advantages of gamma knives enhance performance and usability, solidifying the significant impact on the growth of the overall radiotherapy/radiation oncology devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall radiotherapy/radiation oncology devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the radiotherapy/radiation oncology devices market. This can be attributed to several factors such as rising cancer cases, supportive government policies in increasing focus promoting oncology research, combined with significant advancements in product development and regulatory approvals are acting as key factors that contribute to the growth of the radiotherapy/radiation oncology devices market in the North America region during the forecast period from 2024 to 2030.

National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it is estimated that prostate, lung, and colorectal cancers are expected to represent approximately 48% of all cancer diagnoses in men. For women, the most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.

According to Global Cancer Observatory's data (2024), in 2022, the US represented 89.1% of all cancer cases and Canada represented 10.9% of all cancer cases in the region.

With the US expected to account for a substantial proportion of these cancer cases, healthcare providers are compelled to enhance their cancer treatment capabilities, leading to greater investment in advanced radiation therapies. This growing patient population necessitates innovative and effective treatment options, thereby expanding the market for the same.

The US Food and Drug Administration also provides a supportive environment for newer technologies to reach the market with the provision of "breakthrough device" designation to emerging technologies and products in the medical devices domain. For instance, in February 2022, GenesisCare announced that it enrolled the first patients in a trial for Boston Scientific's SpaceOAR Vue hydrogel. Boston Scientific's SpaceOAR Vue hydrogel will be evaluated in the SABRE trial, sponsored by Boston Scientific, for prostate cancer patients receiving stereotactic body radiation therapy (SBRT).

The increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for radiotherapy/radiation oncology devices. For instance, in October 2021, the US Food and Drug Administration (FDA) granted breakthrough device designation to Alpha Tau's alpha-radiation cancer therapy to treat patients suffering from recurrent glioblastoma multiforme (GBM).

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the radiotherapy/radiation oncology devices market during the forecast period from 2024 to 2030.

Radiotherapy/Radiation Oncology Devices Market key players:

Some the key market players operating in the radiotherapy/radiation oncology devices market include Siemens Healthineers AG, Elekta AB, Accuray Incorporated, BA Worldwide, BD, Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., iCAD, Inc., IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, and others.

Recent Developmental Activities in the Radiotherapy/Radiation Oncology Devices Market:

  • In October 2023, Philips highlighted the latest advances in CT and MR for precision radiation therapy planning at ASTRO 2023.
  • In February 2022, GT Medical Technologies Inc., creators of GammaTile Therapy announced its 2021 roster of ELITE Distinguished Brain Tumor Specialists that have completed 10 or more GammaTile Therapy procedures in 2021.
  • In December 2021, RefleXion Medical Inc. announced that the U.S. Food and Drug Administration (FDA) granted the company Breakthrough Device Designation for its biology-guided radiotherapy* (BgRT) for use in treating lung tumors.

Key takeaways from the Radiotherapy/Radiation Oncology Devices market report study

  • Market size analysis for current radiotherapy/radiation oncology devices market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the radiotherapy/radiation oncology devices market
  • Various opportunities available for other competitors in the radiotherapy/radiation oncology devices market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current radiotherapy/radiation oncology devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for radiotherapy/radiation oncology devices market growth in the coming future?

Target audience who can be benefited from this Radiotherapy/Radiation Oncology Devices market report study

  • Radiotherapy/radiation oncology devices device providers
  • Research organizations and consulting companies
  • Radiotherapy/radiation oncology devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in radiotherapy/radiation oncology devices
  • Various end-users who want to know more about the radiotherapy/radiation oncology devices market and the latest developments in the radiotherapy/radiation oncology devices market

Frequently Asked Questions for the Radiotherapy/Radiation Oncology Devices Market:

1. What are radiotherapy/radiation oncology devices?

  • Radiation therapy uses high-energy X-rays or other particles to destroy tumor cells. It is used to slow or stop the growth of a tumor and is typically given after surgery and possibly along with chemotherapy. The most common type of radiation treatment is called external-beam radiation therapy, which is radiation given from a machine outside the body. When radiation treatment is given using implants, it is called internal radiation therapy or brachytherapy.

2. What is the market for radiotherapy/radiation oncology devices?

  • The radiotherapy/radiation oncology devices market is projected to grow at a 7.78% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the radiotherapy/radiation oncology devices market?

  • The radiotherapy/radiation oncology devices market is growing significantly due to the increasing cases of different types of cancers among population, introduction of innovative product portfolio by the market key players, and growing awareness for early detection are factors that are expected to escalate the overall growth of the radiotherapy/radiation oncology devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the radiotherapy/radiation oncology devices market?

  • Some of the major market players operating in the radiotherapy/radiation oncology devices market include Siemens Healthineers AG, Elekta AB, Accuray Incorporated, BA Worldwide, BD, Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., iCAD, Inc., IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, and others.

5. Which region has the highest share in the radiotherapy/radiation oncology devices market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the radiotherapy/radiation oncology devices market. This can be attributed to several factors such as rising cancer cases, supportive government policies in increasing focus promoting oncology research, combined with significant advancements in product development and regulatory approvals are acting as key factors that contribute to the growth of the radiotherapy/radiation oncology devices market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Radiotherapy/Radiation Oncology Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Radiotherapy/Radiation Oncology Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Radiotherapy/Radiation Oncology Devices Market Key Factors Analysis

  • 5.1. Radiotherapy/Radiation Oncology Devices Market Drivers
    • 5.1.1. Increasing instances of cancer
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Growing awareness for early detection
    • 5.1.4. Improved healthcare infrastructure
  • 5.2. Radiotherapy/Radiation Oncology Devices Market Restraints and Challenges
    • 5.2.1. Risk factors associated with radiation
    • 5.2.2. Availability of alternative therapies
  • 5.3. Radiotherapy/Radiation Oncology Devices Market Opportunities
    • 5.3.1. Combination of therapies associated with multimodal approach

6. Radiotherapy/Radiation Oncology Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Radiotherapy/Radiation Oncology Devices Market Assessment

  • 7.1. By Type
    • 7.1.1. External Beam Radiation Therapy
      • 7.1.1.1. Linear Accelerators (Linac)
      • 7.1.1.2. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
      • 7.1.1.2.1 Gamma Knife
      • 7.1.1.2.2 CyberKnife
      • 7.1.1.2.3 TomoTherapy
      • 7.1.1.3. Proton Therapy
      • 7.1.1.4. Cyclotron
      • 7.1.1.5. Synchrotron
      • 7.1.1.6. Others
    • 7.1.2. Internal Beam Radiotherapy/Brachytherapy
  • 7.2. By Technology
    • 7.2.1. External Beam Radiation Therapy
      • 7.2.1.1. Image-Guided Radiotherapy (IGRT)
      • 7.2.1.2. Intensity Modulated Radiotherapy (IMRT)
      • 7.2.1.3. Stereotactic Technology
      • 7.2.1.4. Proton Beam Therapy
      • 7.2.1.5. 3D Conformal Radiotherapy (3D CRT)
      • 7.2.1.6. Others
    • 7.2.2. Internal Beam Radiotherapy/Brachytherapy
      • 7.2.2.1. Low-Dose Rate Brachytherapy
      • 7.2.2.2. High-Dose Rate Brachytherapy
  • 7.3. By Application
    • 7.3.1. External Beam Radiation Therapy
      • 7.3.1.1. Prostate Cancer
      • 7.3.1.2. Breast Cancer
      • 7.3.1.3. Lung Cancer
      • 7.3.1.4. Head and Neck Cancer
      • 7.3.1.5. Colorectal Cancer
      • 7.3.1.6. Others
    • 7.3.2. Internal Beam Radiation Therapy
      • 7.3.2.1. Prostate Cancer
      • 7.3.2.2. Gynecological Cancer
      • 7.3.2.3. Breast Cancer
      • 7.3.2.4. Cervical Cancer
      • 7.3.2.5. Penile Cancer
      • 7.3.2.6. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Independent Radiotherapy Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Radiotherapy/Radiation Oncology Devices market size in USD million (2021-2030)
      • 7.5.2.5. Spain Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.3.3. India Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Radiotherapy/Radiation Oncology Devices Market Size in USD million (2021-2030)

8. Radiotherapy/Radiation Oncology Devices Market Company and Product Profiles

  • 8.1. Siemens Healthineers AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Elekta AB
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Accuray Incorporated
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. IBA Worldwide
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. BD
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Isoray Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Mevion Medical Systems
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Viewray Technologies, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Eckert & Ziegler BEBIG
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. ZEISS
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. GT Medical Technologies, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Hitachi, Ltd.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. iCAD, Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. IntraOp Medical, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Panacea Medical Technologies Pvt. Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. SIT - S.I.T. Sordina IORT Technologies S.p.A.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Sensus Healthcare, Inc.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Theragenics
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Optivus Proton Therapy, Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. P-cure
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Radiotherapy/Radiation Oncology Devices Market in Global (2021-2030)
  • Table 3: Radiotherapy/Radiation Oncology Devices Market in Global by Type (2021-2030)
  • Table 4: Radiotherapy/Radiation Oncology Devices Market in Global by Technology (2021-2030)
  • Table 5: Radiotherapy/Radiation Oncology Devices Market in Global by Application (2021-2030)
  • Table 6: Radiotherapy/Radiation Oncology Devices Market in Global by End-User (2021-2030)
  • Table 7: Radiotherapy/Radiation Oncology Devices Market in Global by Geography (2021-2030)
  • Table 8: Radiotherapy/Radiation Oncology Devices Market in North America (2021-2030)
  • Table 9: Radiotherapy/Radiation Oncology Devices Market in the United States (2021-2030)
  • Table 10: Radiotherapy/Radiation Oncology Devices Market in Canada (2021-2030)
  • Table 11: Radiotherapy/Radiation Oncology Devices Market in Mexico (2021-2030)
  • Table 12: Radiotherapy/Radiation Oncology Devices Market in Europe (2021-2030)
  • Table 13: Radiotherapy/Radiation Oncology Devices Market in France (2021-2030)
  • Table 14: Radiotherapy/Radiation Oncology Devices Market in Germany (2021-2030)
  • Table 15: Radiotherapy/Radiation Oncology Devices Market in United Kingdom (2021-2030)
  • Table 16: Radiotherapy/Radiation Oncology Devices Market in Italy (2021-2030)
  • Table 17: Radiotherapy/Radiation Oncology Devices Market in Spain (2021-2030)
  • Table 18: Radiotherapy/Radiation Oncology Devices Market in the Rest of Europe (2021-2030)
  • Table 19: Radiotherapy/Radiation Oncology Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Radiotherapy/Radiation Oncology Devices Market in China (2021-2030)
  • Table 21: Radiotherapy/Radiation Oncology Devices Market in Japan (2021-2030)
  • Table 22: Radiotherapy/Radiation Oncology Devices Market in India (2021-2030)
  • Table 23: Radiotherapy/Radiation Oncology Devices Market in Australia (2021-2030)
  • Table 24: Radiotherapy/Radiation Oncology Devices Market in South Korea (2021-2030)
  • Table 25: Radiotherapy/Radiation Oncology Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Radiotherapy/Radiation Oncology Devices Market in the Rest of the World (2021-2030)
  • Table 27: Radiotherapy/Radiation Oncology Devices Market in the Middle East (2021-2030)
  • Table 28: Radiotherapy/Radiation Oncology Devices Market in Africa (2021-2030)
  • Table 29: Radiotherapy/Radiation Oncology Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Radiotherapy/Radiation Oncology Devices Market in Global (2021-2030)
  • Figure 3: Radiotherapy/Radiation Oncology Devices Market in Global by Type (2021-2030)
  • Figure 4: Radiotherapy/Radiation Oncology Devices Market in Global by Technology (2021-2030)
  • Figure 5: Radiotherapy/Radiation Oncology Devices Market in Global by Application (2021-2030)
  • Figure 6: Radiotherapy/Radiation Oncology Devices Market in Global by End-User (2021-2030)
  • Figure 7: Radiotherapy/Radiation Oncology Devices Market in Global by Geography (2021-2030)
  • Figure 8: Radiotherapy/Radiation Oncology Devices Market in North America (2021-2030)
  • Figure 9: Radiotherapy/Radiation Oncology Devices Market in the United States (2021-2030)
  • Figure 10: Radiotherapy/Radiation Oncology Devices Market in Canada (2021-2030)
  • Figure 11: Radiotherapy/Radiation Oncology Devices Market in Mexico (2021-2030)
  • Figure 12: Radiotherapy/Radiation Oncology Devices Market in Europe (2021-2030)
  • Figure 13: Radiotherapy/Radiation Oncology Devices Market in France (2021-2030)
  • Figure 14: Radiotherapy/Radiation Oncology Devices Market in Germany (2021-2030)
  • Figure 15: Radiotherapy/Radiation Oncology Devices Market in United Kingdom (2021-2030)
  • Figure 16: Radiotherapy/Radiation Oncology Devices Market in Italy (2021-2030)
  • Figure 17: Radiotherapy/Radiation Oncology Devices Market in Spain (2021-2030)
  • Figure 18: Radiotherapy/Radiation Oncology Devices Market in the Rest of Europe (2021-2030)
  • Figure 19: Radiotherapy/Radiation Oncology Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Radiotherapy/Radiation Oncology Devices Market in China (2021-2030)
  • Figure 21: Radiotherapy/Radiation Oncology Devices Market in Japan (2021-2030)
  • Figure 22: Radiotherapy/Radiation Oncology Devices Market in India (2021-2030)
  • Figure 23: Radiotherapy/Radiation Oncology Devices Market in Australia (2021-2030)
  • Figure 24: Radiotherapy/Radiation Oncology Devices Market in South Korea (2021-2030)
  • Figure 25: Radiotherapy/Radiation Oncology Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Radiotherapy/Radiation Oncology Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Radiotherapy/Radiation Oncology Devices Market in the Middle East (2021-2030)
  • Figure 28: Radiotherapy/Radiation Oncology Devices Market in Africa (2021-2030)
  • Figure 29: Radiotherapy/Radiation Oncology Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis